Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy ; volume:9 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (3.4.2019), 1-8, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Jeong, Shin Young
Lee, Sang-Woo
Kim, Wan Wook
Jung, Jin Hyang
Lee, Won Kee
Ahn, Byeong-Cheol
Lee, Jaetae
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42083-3
- URN
-
urn:nbn:de:101:1-2019041922555749575831
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jeong, Shin Young
- Lee, Sang-Woo
- Kim, Wan Wook
- Jung, Jin Hyang
- Lee, Won Kee
- Ahn, Byeong-Cheol
- Lee, Jaetae
- SpringerLink (Online service)
Other Objects (12)
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment
Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment
Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment